FDA suspects meningitis risk with 2 more NECC drugs; Novartis clings to 69% share of Diovan HCT sales;

@FiercePharma: Other compounded drugs may be tied into meningitis outbreak, FDA says. Another NECC steroid + NECC heart drug. More | Follow @FiercePharma

> Two more drugs sold by New England Compounding are suspected in the growing meningitis outbreak, which has so far killed 15 patients and sickened more than 200. Report | Report

> Three weeks after its U.S. patent expiration, Novartis ($NVS) has kept 69% of the market for Diovan HCT, a combination version of its hypertension drug, in part because of its own authorized generic version. Report

> Sanofi ($SNY) is expanding its Turkish operations to make a production plant in Luleburgaz a hub for antibiotics export to 40 countries. Report

> Novo Nordisk ($NVO) filed for regulatory approval of its new hemophilia treatment turoctocog alfa in Europe and the U.S. Report | Release

> Ireland's Jazz Pharmaceuticals said it wrapped up the sale of its women's health business to Sweden's Meda. Report

Medical Device News

 @FierceMedDev: JNJ pulled in $7.1 billion from medical devices and diagnostics in Q3, a 12.5% jump. More | Follow @FierceMedDev

 @MarkHFierce: Patients in India thrived with used ICD implants. Can this be done on a broader scale? More | Follow @MarkHFierce

 @DamianFierce: Medtronic is buying a $66.2M stake in China's LifeTech Scientific, makers of cardiovascular devices. More | Follow @DamianFierce

> Amid Dx sales growth, Roche Diagnostics considers another buy. News

> Lanx draws $8.7M for spinal fusion device development. Item

Biotech News

 @FierceBiotech: New special report on FierceVaccines.com: 10 promising therapeutic vaccines in 2012. Feature | Follow @FierceBiotech

 @JohnCFierce: Genzyme, likely to get some tough safety questions on Kynamro at this week's FDA panel. More | Follow @JohnCFierce

 @RyanMFierce: Piramal is poised to be a big consolidator in pharma services/manufacturing, but apparently only at the right price. More | Follow @RyanMFierce

> FDA frets over safety of Genzyme's rival drug for rare cholesterol disease. Article

> Bullish Roche talks targeted takeovers, showcases T-DM1's prospects. Story

> ArQule, Threshold get a bounce out of PhIII SPA pacts with FDA. Report

Biotech Research News

> NIH funds Advanced Cancer Therapeutics' preclinical brain cancer drug work. Report

> Scientists flee $3B Texas cancer research fund. Item

> Alnylam, Tel Aviv U develop RNAi drugs to fight rare blood cancer. Article

> Alzheimer's drug builds new brain cell connections in rats. News

> Scientists build neural-like stem cells from mouse muscle tissue. Story

Pharma Manufacturing News

> GSK cancels plans to close Stiefel plant in Ireland. Story

> Cinven continues generics deal spree with Amdipharm buy. Article

> Teva Pharma opens $110M plant in Hungary. News

> Analysis: Compounding groups fought FDA oversight before NECC disaster. Report

And Finally... A CVS Caremark unit agreed to pay $5.25 million to settle claims that it misrepresented prices of certain Medicare prescription drugs, the Department of Justice said. Report